Safety and efficacy of transitioning from selexipag to oral treprostinil in pulmonary arterial hypertension: Findings from the ADAPT registry.

Lachant, D; Minkin, R; Swisher, J; Mogri, M; Zolty, R; Hwang, S; Seaman, S; Broderick, M; Sahay, S

Lachant, D; Minkin, R; Swisher, J; Mogri, M; Zolty, R; Hwang, S; Seaman, S; Broderick, M; Sahay, S.

Afiliación

Lachant D; University of Rochester Medical Center, 601 Elmwood Ave, Rochester, NY, 14642, USA. Electronic address: daniel_lachant@urmc.rochester.edu.
Minkin R; New York-Presbyterian Brooklyn Methodist Hospital, 506 6th St, Brooklyn, NY, 11215, USA. Electronic address: rum9030@nyp.org.
Swisher J; Fort Sanders Regional Medical Center, 1901 Clinch Ave, Knoxville, TN, 37916, USA. Electronic address: jswisher@comcast.net.
Mogri M; Baylor Scott & White Health, 301 North Washington Avenue Dallas, TX, 75246, USA. Electronic address: mohammed.mogri@bswhealth.org.
Zolty R; University of Nebraska Medical Center, 42nd and Emile St, Omaha, NE, 68198, USA. Electronic address: ronald.zolty@unmc.edu.
Hwang S; United Therapeutics Corporation, 55 TW Alexander Dr, Durham, NC, 27709, USA. Electronic address: shwang@unither.com.
Seaman S; United Therapeutics Corporation, 55 TW Alexander Dr, Durham, NC, 27709, USA. Electronic address: sseaman@unither.com.
Broderick M; United Therapeutics Corporation, 55 TW Alexander Dr, Durham, NC, 27709, USA. Electronic address: mbroderick@unither.com.
Sahay S; Houston Methodist Lung Center, 6445 Main St Floor 22, Houston, TX, 77030, USA. Electronic address: ssahay@houstonmethodist.org.

Pulm Pharmacol Ther ; 82: 102232, 2023 10.

Article en En | MEDLINE | ID: mdl-37451609

Asunto(s)

Hipertensión Pulmonar; Hipertensión Arterial Pulmonar; Humanos; Hipertensión Arterial Pulmonar/tratamiento farmacológico; Antihipertensivos; Hipertensión Pulmonar/tratamiento farmacológico; Estudios Prospectivos; Administración Oral; Epoprostenol/efectos adversos; Hipertensión Pulmonar Primaria Familiar/tratamiento farmacológico; Sistema de Registros

Palabras clave

ADAPT; Oral treprostinil; REPLACE; REVEAL Lite 2 risk strata; Selexipag

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hipertensión Arterial Pulmonar / Hipertensión Pulmonar Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Pulm Pharmacol Ther Asunto de la revista: FARMACOLOGIA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google